These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 20189842

  • 1. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
    Williams SB, Kacker R, Steele GS, Richie JP.
    Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
    [Abstract] [Full Text] [Related]

  • 2. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J.
    Cancer; 2007 Feb 01; 109(3):528-35. PubMed ID: 17177200
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H, Nichols C, Daneshmand S.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2388-93. PubMed ID: 22395993
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Mar 20; 25(9):1033-7. PubMed ID: 17261854
    [Abstract] [Full Text] [Related]

  • 5. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA, Bihrle R, Foster RS.
    Urology; 2008 May 20; 71(5):911-4. PubMed ID: 18342916
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
    Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL.
    Cancer; 2009 Mar 15; 115(6):1310-7. PubMed ID: 19156903
    [Abstract] [Full Text] [Related]

  • 7. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Oct 01; 25(28):4365-9. PubMed ID: 17906201
    [Abstract] [Full Text] [Related]

  • 8. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP.
    BJU Int; 2010 Sep 01; 106(6):779-85. PubMed ID: 20089110
    [Abstract] [Full Text] [Related]

  • 9. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 10. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M, Malavaud B, Bayoud Y, Sebe P, Hoepffner JL, Salomon L, Houlgatte A, Pignot G, Rigaud J, Fléchon A, Pfister C, Rouprêt M, Soulié M, Méjean A, Durand X.
    J Surg Oncol; 2016 Dec 01; 114(8):992-996. PubMed ID: 27859263
    [Abstract] [Full Text] [Related]

  • 11. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M, Beck S, Bihrle R, Einhorn L, Foster R.
    BJU Int; 2009 Jul 01; 104(2):176-8. PubMed ID: 19493258
    [Abstract] [Full Text] [Related]

  • 12. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL, Foster RS, Rowland RG, Bihrle R, Smith ER, Einhorn LH, Roth BJ, Donohue JP.
    Urology; 1997 Dec 01; 50(6):957-62. PubMed ID: 9426730
    [Abstract] [Full Text] [Related]

  • 13. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.
    Williams SB, McDermott DW, Winston D, Bahnson E, Berry AM, Steele GS, Richie JP.
    BJU Int; 2010 Apr 01; 105(7):918-21. PubMed ID: 19747353
    [Abstract] [Full Text] [Related]

  • 14. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB, McDermott DW, Dock W, Bahnson E, Berry AM, Steele GS, Richie JP.
    J Urol; 2009 May 01; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.
    Ai Zheng; 2008 Dec 01; 27(12):1302-6. PubMed ID: 19079998
    [Abstract] [Full Text] [Related]

  • 16. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A, Carver BS, Stasi J, Bajorin DF, Motzer RJ, Bosl GJ, Sheinfeld J.
    Cancer; 2008 Feb 15; 112(4):800-5. PubMed ID: 18172902
    [Abstract] [Full Text] [Related]

  • 17. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ, Murray N, Coppin C, Kollmannsberger C, Man A, Chi KN.
    J Urol; 2005 Dec 15; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [Abstract] [Full Text] [Related]

  • 18. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C, Raman JD, Sheinfeld J, Albers P.
    BJU Int; 2009 Nov 15; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [Abstract] [Full Text] [Related]

  • 19. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB, Steele GS, Richie JP.
    J Urol; 2009 Dec 15; 182(6):2716-20. PubMed ID: 19836777
    [Abstract] [Full Text] [Related]

  • 20. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P, Beck SD, Cheng L, Masterson TA, Bihrle R, Kesler K, Foster RS.
    J Urol; 2013 Sep 15; 190(3):874-7. PubMed ID: 23517745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.